Harvard Bioscience, Inc.HBIONASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-1.82M
↓ 166% below average
Average (9y)
$2.75M
Historical baseline
Range
High:$11.72M
Low:$-2.27M
CAGR
-2.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-1.82M | -115.6% |
| 2023 | $11.72M | +2775.1% |
| 2022 | $-438000.00 | -427.7% |
| 2021 | $-83000.00 | -101.0% |
| 2020 | $8.18M | +19.7% |
| 2019 | $6.83M | +403.0% |
| 2018 | $1.36M | +713.2% |
| 2017 | $167000.00 | -95.7% |
| 2016 | $3.90M | +271.8% |
| 2015 | $-2.27M | - |